OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
August 15, 2019
The European Commission has approved an extension of the use of Dupixent (dupilumab) within the EU to include patients aged 12 to 17 years old with moderate-to-severe atopic dermatitis.
August 02, 2019
Homogeneity of the powder blend is crucial for solid-dosage drug manufacturing.
Complex and potent molecules demand greater technical and regulatory expertise to ensure safe handling.
Glass vials have come a long way from mere commodities and are now considered an integral part of final drug product.
Formulators of parenteral drugs must be cautious of specific considerations and challenges that arise during development and manufacture.
As patient-centered therapies and clinical trials become more important, innovation is providing more control and transparency in the way that pharmaceuticals are delivered.
August 01, 2019
Industry experts discuss the role of gene-editing techniques in regenerative medicine and cell-line development.
Biopharma industry faces production challenges as gene therapies move from clinical to commercialization.
Mass-produce cell and gene therapies presents the biopharma industry with a unique set of challenges.
Researchers in China are playing a role in advancing gene therapy development.